Health Economics & Outcomes Research (HEOR)

We provide insights and analysis on potential market size and the design of rigorous economic evaluations, such as clinical studies and cost-effectiveness analysis.

Litigation Support

Our health economics analysis, advice and testimony support a wide range of healthcare litigation. We also provide expert services and testimony.

Policy Analysis

Our extensive knowledge and experience enables us to apply health economics analysis to a wide variety of health-related policy issues.

Business Analytics & Management Consulting

We apply health economics analysis to a wide variety of health care business management and strategy problems to help health care businesses improve efficiency, improve market share, and expand market boundaries.

Meet Our Team

About

Health Economics & Outcomes Research

Led by Director and Principal Andrew Briggs, DPhil, and CEO John Schneider, PhD, AHE researchers and consultants have extensive knowledge and experience in the field of health economics and outcomes research (HEOR). These services include a wide variety of offerings across the product development continuum. In the early stages of development, we provide insights and analysis on potential market size and the design of rigorous economic evaluations, such as clinical studies and cost-effectiveness analysis.

About

Litigation Support

Led by Director Cara Scheibling and CEO John Schneider, PhD, AHE researchers and consultants have extensive knowledge and experience providing health economics analysis, advice and testimony in support of a wide range of healthcare litigation. Two other Avalon experts—James Robinson, PhD, and Robert Ohsfeldt, PhD—also support this practice area by providing expert services and testimony. Areas of experience and expertise include antitrust, trademark infringement, reputational harm, payer-provider disputes, and reasonable value of medical costs.

News

  • December 1, 2017
    Avalon CEO John Schneider will be speaking at the ...
    Avalon CEO John Schneider will be speaking at the 4th Annual Conference on Health Outcomes, Data Communications, Market Access and Value-Based Contracting in Philadelphia, January 22-24, 2018.

    CONTINUE READING...
  • October 1, 2017
    Avalon CEO John Schneider will be presenting on th...
    Avalon CEO John Schneider will be presenting on the panel of "Blockchain Use-Cases, Brainstorm: Replacing the Middleman: Healthcare, Retail, Finance and More" at the Blockchain Economic Forum 2017 in ...

    CONTINUE READING...
  • October 1, 2017
    Avalon Health Economics at the 20th Annual Europea...
    In our work in health economics and outcomes research (HEOR) for the life sciences, including biotechnology, pharmaceuticals, and medical devices, we must maintain close ties with our colleagues and s...

    CONTINUE READING...
  • April 1, 2017
    AHE Presents: Symposium on Emerging Trends in U.S....
    Avalon Health Economics Presents: Symposium on Emerging Trends in U.S. Health Economic Evaluation: A Closer Look at the Role of Cost Effectiveness in U.S. Market Access Tuesday, May 9th at the Hy...

    CONTINUE READING...
  • February 22, 2017
    The Value of Biopharmaceutical Innovation in the U...
    There have been some negative reports recently regarding the pricing practices of some pharmaceutical companies. However, it is important to give at least equal consideration to the value derived from...

    CONTINUE READING...
  • December 7, 2016
    The Evolving Landscape of U.S. Payer Coverage Deci...
    Although there are a large number of public and private payers in the U.S., medical device and pharmaceutical manufacturers generally focus on two types of payers: (1) Medicare, which is administered ...

    CONTINUE READING...

Contact Us

Have a question or interested in learning more? Contact us!